Tarmim Ava

Tarmim Ava organization with official name (Tarmim Ava Baran) was established with the help of God in February 2020. The goals of the company are to develop technical and indigenous knowledge in the field of regenerative medicine. The company's activities in the field of tissue engineering are focused on the commercialization of dermal substitutes, biopatches and nanobiopatchs, and advance dressings in the field of wounds and burns. Other products of the company include solutions needed for infertility treatment and PRP kit, which will enter the market soon. Following the global outbreak of the COVID virus, the Tarmim Ava organization, with its technical knowledge and infrastructure, has put on the agenda the production of a mesenchymal stem cell-derived drug under the brand name Mezexo. Also, Tarmim Ava organization, focusing on new therapies of paracrine therapy in the field of stem cells, is performing clinical human trials in the fields of skin, hair, eyes and orthopedics.

• Employees1